| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.028 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |